The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

CLIN CLINIGEN GROUP PLC ORD 0.1P



Income Statement  (£ m) 30-Jun-10 30-Jun-11 30-Jun-12 30-Jun-13 30-Jun-14
Continuing Operations
Revenue  21.27 35.02 82.15 122.58 126.64
Operating Profit/(Loss)  1.24 7.14 10.54 14.60 21.52
Net Interest  0.01 0.39 0.28 0.10 0.23
Profit Before Tax  1.23 6.75 10.25 14.51 21.28
Profit After Tax  0.91 4.32 6.60 11.33 16.21
Discontinued Operations
Profit After Tax  0.00 0.00 0.00 0.00 0.00
PROFIT FOR THE PERIOD  0.91 4.32 6.60 11.33 16.21
Attributable to:
Minority Interests  0.00 0.00 0.00 0.00 0.00
Equity Holders of Parent Company  0.91 4.32 6.60 11.33 16.21
 
Continuing EPS
Earnings per Share - Basic  1.11p 5.23p 13.20p 15.10p 19.60p
Earnings per Share - Diluted  1.11p 5.23p 8.70p 13.80p 19.00p
Earnings per Share - Adjusted  1.11p 5.23p 13.40p 20.10p 24.50p
Continuing and Discontinued EPS
Earnings per Share - Basic  1.11p 5.23p 13.20p 15.10p 19.60p
Earnings per Share - Diluted  1.11p 5.23p 8.70p 13.80p 19.00p
Earnings per Share - Adjusted  1.11p 5.23p 13.40p 20.10p 24.50p
 
Dividend per Share  0.00p 0.00p 0.00p 0.60p 3.00p

Balance Sheet  (£ m) 30-Jun-10 30-Jun-11 30-Jun-12 30-Jun-13 30-Jun-14
Assets
Non-Current Assets
Property, Plant & Equipment  0.10 0.07 0.43 0.75 0.97
Intangible Assets  15.74 14.68 15.34 38.89 50.51
Investment Properties  0.00 0.00 0.00 0.00 0.00
Investments  0.00 0.00 0.00 0.00 0.00
Other Financial Assets  0.00 0.00 0.00 0.00 0.00
Other Non-Current Assets  0.00 0.22 10.12 1.98 1.96
  15.84 14.96 25.90 41.62 53.43
Current Assets
Inventories  0.06 0.90 2.79 3.15 2.47
Trade & Other Receivables  1.44 3.89 14.56 22.65 27.18
Cash at Bank & in Hand  2.21 10.01 5.20 11.33 21.79
Current Asset Investments  0.00 0.00 0.00 0.00 0.00
Other Current Assets  0.00 0.00 0.00 0.00 0.00
  3.70 14.80 22.55 37.13 51.43
 
Total Assets  19.54 29.76 48.45 78.75 104.86
 
Liabilities
Current Liabilities
Borrowings  -0.91 -1.18 -1.63 0.00 -16.50
Other Current Liabilities  -5.71 -14.16 -16.92 -27.80 -22.06
  -6.61 -15.34 -18.54 -27.80 -38.56
 
Net Current Assets  -2.91 -0.54 4.01 9.33 12.88
 
Non-Current Liabilities
Borrowings  -4.86 -4.13 0.00 0.00 0.00
Provisions  -0.01 0.00 0.00 0.00 0.00
Other Non-Current Liabilities  -2.11 0.00 0.00 0.00 0.00
  -6.97 -4.13 0.00 0.00 0.00
 
Other Liabilities  n/a n/a n/a n/a n/a
Total Liabilities  -13.59 -19.47 -18.54 -27.80 -38.56
 
Net Assets  5.95 10.29 29.91 50.95 66.31
 
Capital & Reserves
Share Capital  0.00 0.00 0.00 0.08 0.08
Share Premium Account  0.00 0.00 0.00 8.66 8.66
Other Reserves  5.46 5.48 5.51 5.52 4.94
Retained Earnings  0.49 4.81 24.40 36.69 52.62
Shareholders Funds  5.95 10.29 29.91 50.95 66.31
 
Minority Interests/Other Equity  0.00 0.00 0.00 0.00 0.00
Total Equity  5.95 10.29 29.91 50.95 66.31

Ratios - based on IFRS 30-Jun-10 30-Jun-11 30-Jun-12 30-Jun-13 30-Jun-14
Continuing Operations
PE Ratio - Adjusted  n/a n/a n/a 14.93 15.42
PEG - Adjusted  n/a n/a n/a 0.30 0.70
Earnings per Share Growth - Adjusted  n/a 373.12% 156.31% 50.00% 21.89%
Dividend Cover  n/a n/a n/a 33.50 8.17
Revenue Per Share  25.77p 42.42p 164.03p 163.84p 153.40p
Pre-Tax Profit per Share  1.49p 8.18p 20.47p 19.40p 25.78p
Operating Margin  5.85% 20.40% 12.83% 11.91% 16.99%
Return on Capital Employed  -31.00% 774.00% 65.08% 121.15% 66.62%
 
Continuing & Discontinued Operations
Dividend Yield  n/a n/a n/a 0.20% 0.79%
Dividend per Share Growth  n/a n/a n/a n/a 400.00%
Net Asset Value per Share (exc. Intangibles)  -11.85p -5.32p 17.64p 14.60p 19.14p
Net Gearing  59.84% -45.66% -11.94% -22.23% -7.97%

Data is provided by Morningstar


Company Information
Updated Monthly
Company address Pitcairn House, Crown Square, Centrum 100, Burton-on-Trent, DE14 2WW, United Kingdom
Company website http://www.clinigengrou...
Market cap(in millions)* £ 811.30
Listing/Admission to trading 25 Sep 2012
Trading service -
Market -
Listing category -
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
04-Aug-15
FTSE index FTSE AIM All-Share,FTSE AIM 100,FTSE AIM UK 50,FTSE AIM All-Share - Health Care
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Biotechnology
Country of share register -
Segment -
MiFID Status -
Exchange market size -
SEDOL -
ISIN number -



CLINIGEN share - fundamentals